Savara Inc (SVRA):企業の財務・戦略的SWOT分析

◆英語タイトル:Savara Inc (SVRA) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDME185401FSA
◆発行会社(調査会社):GlobalData
◆発行日:2020年12月
◆ページ数:48
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Savara Inc (SVRA) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Savara Inc (Savara), formerly Mast Therapeutics Inc, is a clinical stage biopharmaceutical company, which develops therapies for the treatment of rare respiratory diseases, including cystic fibrosis (CF), and pulmonary alveolar proteinosis (PAP). The company’s lead product candidates include Molgradex, an inhaled formulation of recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF) for the treatment of treatment of PAP; and AeroVanc, an inhaled formulation of vancomycin for the treatment of CF. The company has subsidiaries in the US and Denmark. Savara is headquartered in Austin, Texas, the US.

Savara Inc Key Recent Developments

Dec 10,2020: Savara provides pipeline and business update
Nov 05,2020: Savara reports third quarter 2020 financial results and provides business update
Sep 11,2020: Savara announces Senior Management Changes
Aug 06,2020: Savara reports second quarter 2020 financial results and provides business update
May 27,2020: SAVARA: Election of directors

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Savara Inc – Key Facts
Savara Inc – Key Employees
Savara Inc – Key Employee Biographies
Savara Inc – Major Products and Services
Savara Inc – History
Savara Inc – Company Statement
Savara Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Savara Inc – Business Description
R&D Overview
Savara Inc – SWOT Analysis
SWOT Analysis – Overview
Savara Inc – Strengths
Savara Inc – Weaknesses
Savara Inc – Opportunities
Savara Inc – Threats
Savara Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Savara Inc, Medical Equipment, Deals By Year, 2014 to YTD 2020
Savara Inc, Medical Equipment, Deals By Type, 2014 to YTD 2020
Savara Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Dec 10, 2020: Savara provides pipeline and business update
Nov 05, 2020: Savara reports third quarter 2020 financial results and provides business update
Sep 11, 2020: Savara announces Senior Management Changes
Aug 06, 2020: Savara reports second quarter 2020 financial results and provides business update
May 27, 2020: SAVARA: Election of directors
May 07, 2020: Savara reports first quarter 2020 financial results and provides business update
Mar 30, 2020: Savara provides business update in response to COVID-19 pandemic
Mar 12, 2020: Savara reports fourth quarter / year-end 2019 financial results and provides business update
Dec 03, 2019: Savara announces the appointment of Dr. An van Es-Johansson to board of directors
Nov 07, 2019: Savara reports third quarter 2019 financial results and provides business update
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Savara Inc, Key Facts
Savara Inc, Key Employees
Savara Inc, Key Employee Biographies
Savara Inc, Major Products and Services
Savara Inc, History
Savara Inc, Subsidiaries
Savara Inc, Key Competitors
Savara Inc, Ratios based on current share price
Savara Inc, Annual Ratios
Savara Inc, Annual Ratios (Cont...1)
Savara Inc, Interim Ratios
Savara Inc, Medical Equipment, Deals By Year, 2014 to YTD 2020
Savara Inc, Medical Equipment, Deals By Type, 2014 to YTD 2020
Savara Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Savara Inc (SVRA):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • IBIDEN Co Ltd (4062):企業の財務・戦略的SWOT分析
    IBIDEN Co Ltd (4062) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Lundin Mining Corporation:企業のM&A・事業提携・投資動向
    Lundin Mining Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Lundin Mining Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisi …
  • Lexicon Pharmaceuticals Inc (LXRX):企業の財務・戦略的SWOT分析
    Lexicon Pharmaceuticals Inc (LXRX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Reckitt Benckiser Group plc:企業の戦略・SWOT・財務情報
    Reckitt Benckiser Group plc - Strategy, SWOT and Corporate Finance Report Summary Reckitt Benckiser Group plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Canadian Tire Corp Ltd (CTC.A):企業の財務・戦略的SWOT分析
    Canadian Tire Corp Ltd (CTC.A) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Biocartis Group NV (BCART) – Product Pipeline Analysis, 2018 Uate
    Summary Biocartis Group NV (Biocartis) is a molecular diagnostics company that provides personalized medicine for patients through its molecular diagnostics. The company undertakes the development of diagnostics technology platforms for multiplexed detection of bio-analytes, with oncology as its key …
  • Securitas AB (SECU B):企業の財務・戦略的SWOT分析
    Securitas AB (SECU B) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Pacific Gas and Electric Co:企業の戦略的SWOT分析
    Pacific Gas and Electric Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Cloud Cap Technology Inc.:企業の戦略・SWOT・財務情報
    Cloud Cap Technology Inc. - Strategy, SWOT and Corporate Finance Report Summary Cloud Cap Technology Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Neovasc Inc (NVC):企業の財務・戦略的SWOT分析
    Summary Neovasc Inc (Neovasc) is a medical device manufacturing company that manufactures, develops, and sells cardiovascular disease products. The company’s products include Neovasc reducer, Neovasc tiara, and Neovasc tissue products. Its Neovasc tiara is a novel transcatheter device that is design …
  • Becle S.A.B. de C.V. (CUERVO):企業の財務・戦略的SWOT分析
    Becle S.A.B. de C.V. (CUERVO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Guerbet SA (GBT):医療機器:M&Aディール及び事業提携情報
    Summary Guerbet SA (Guerbet) operates in the contrast-agent field. The company provides a wide range of pharmaceutical products, medical equipments and services for interventional imaging and diagnostic, to improve the diagnosis and treatment of patients. Its major products include diagnostic imagin …
  • BT Group plc:戦略・SWOT・企業財務分析
    BT Group plc - Strategy, SWOT and Corporate Finance Report Summary BT Group plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • WAVE Life Sciences Ltd (WVE):企業の財務・戦略的SWOT分析
    Summary WAVE Life Sciences Ltd (WAVE Life Sciences), formerly WAVE Life Sciences Pte Ltd is a genetic medicine company that develops stereopure nucleic acid therapies. The company's pipeline products comprise multiple oligonucleotide modalities such as exon-skipping and single-stranded RNAi, and ant …
  • PF Atlantic Petroleum (ATLA DKK):石油・ガス:M&Aディール及び事業提携情報
    Summary P/F Atlantic Petroleum (Atlantic Petroleum) is an oil and gas company that offers development of offshore oil projects. The company's services include exploration, appraisal, development, and production programs. It operates its oil and gas interests in the Norwegian Continental Shelf, the U …
  • Meijer Inc:企業の戦略・SWOT・財務情報
    Meijer Inc - Strategy, SWOT and Corporate Finance Report Summary Meijer Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Marshall Aerospace and Defence Group:企業の戦略・SWOT・財務情報
    Marshall Aerospace and Defence Group - Strategy, SWOT and Corporate Finance Report Summary Marshall Aerospace and Defence Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Hanwei Energy Services Corp (HE):企業の財務・戦略的SWOT分析
    Summary Hanwei Energy Services Corp (Hanwei Energy) is a chemical company that develops, manufactures and distributes plastic fibre reinforced piping systems. The company’s products include anhydride and amine cured frp pipes, fittings, fixtures and flanges. It offers client solutions such as pre-te …
  • Verbundnetz Gas Aktiengesellschaft-石油・ガス分野:企業M&A・提携分析
    Summary Verbundnetz Gas Aktiengesellschaft (VNG), a subsidiary of EnBW Energie Baden-Wurttemberg AG, is a natural gas company that explores, produces, stores, trades and transports natural gas. The company has natural gas licenses on the Norwegian continental shelf and the Danish Central Graben regi …
  • Pint Pharma GmbH:製薬・医療:M&Aディール及び事業提携情報
    Summary Pint Pharma GmbH (Pint Pharma), a subsidiary of Pint Pharma International SA, is a developer, manufacturer and marketer of originator drugs in rare disease, oncology and specialty conditions. The company offers its products in the form of tablets, injections, small compounds, drugs, implants …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆